Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Change in Accured Expenses (2016 - 2025)

Arcadia Biosciences' Change in Accured Expenses history spans 12 years, with the latest figure at -$342000.0 for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 147.57% year-over-year to -$342000.0; the TTM value through Dec 2025 reached -$399000.0, changed N/A, while the annual FY2025 figure was -$399000.0, N/A changed from the prior year.
  • Change in Accured Expenses reached -$342000.0 in Q4 2025 per RKDA's latest filing, down from $156000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $971000.0 in Q3 2021 to a low of -$971000.0 in Q4 2021.
  • Average Change in Accured Expenses over 5 years is -$57125.0, with a median of -$1500.0 recorded in 2021.
  • The largest YoY upside for Change in Accured Expenses was 234.9% in 2024 against a maximum downside of 70300.0% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$971000.0 in 2021, then soared by 126.06% to $253000.0 in 2022, then crashed by 310.67% to -$533000.0 in 2023, then soared by 234.9% to $719000.0 in 2024, then plummeted by 147.57% to -$342000.0 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Change in Accured Expenses are -$342000.0 (Q4 2025), $156000.0 (Q2 2025), and -$213000.0 (Q1 2025).